Vietnam produces vaccines to prevent new strains of influenza A / H5N1
Vaccine helps poultry to prevent diseases covering virus strains circulating in Vietnam, researched and produced domestically.
Vaccine helps poultry to prevent diseases covering virus strains circulating in Vietnam, researched and produced domestically.
Navetco Veterinary Medicine Joint Stock Company has just produced 1.5 million doses of A / H5N1 avian influenza vaccine (Navet - Fluvac 2) on an industrial scale to test and test in practice.
Vaccine batches were initially tested at the grassroots level by serological methods, virulence, determined PD50, and rated good. The A / H5N1 Fluvac 2 avian influenza vaccine is currently in the national testing and testing phase.
Vaccine bottling line.
This is the result from the pilot production project "Perfecting the production process of inactivated oil emulsion vaccines against influenza A / H5N1 for poultry due to new strains caused in Vietnam" due to Central Veterinary Drug Joint Stock Company (Navetco) presided over. The project belongs to the National Product Development Program by 2020 chaired by the Ministry of Science and Technology.
Mr. Nguyen Van Dung - Director of Navetco Research Center, the project implementation unit said that by June 2019 the project ended but the progress has now reached 80-90%.
Oil emulsifying system in vaccine production.
Completing the goal, the research team will create a new product Navet Fluvac 2, which includes two types of dual antigens that can protect against avian influenza viruses circulating in Vietnam. Men like H5N1 with different branches 1.1, 2.3.2.1.c and H5N6.
"When there is this vaccine, the ability to prevent diseases can cover the viruses that are circulating in Vietnam. In the coming time, Vietnam will not have to import vaccines due to active production in the country, the price is much lower. compared with foreign imports, " Dung said.
The Management Board of the National Product Development Program Office until 2020 inspects the progress of project implementation in July 2018.
Mr. Dung said, in order to achieve this, the company received support from the Office of Programs from the time of proposal, construction until the project implementation. The two sides regularly connect, report progress and check the reality, remove problems during implementation.
The investment of funds for active research of original breeds is very important, thereby creating new, suitable antigens for viruses circulating in Vietnam.
"We are working with the original Biotechnology Research Institute for Biotechnology to take the initiative in reverse genetics to create new strains with new strains occurring in Vietnam," Dung said.
Science and technology projects Production of A / H5N1 influenza vaccines for poultry is carried out with the following contents:
- Studying the production of inactivated oil emulsion vaccine against influenza A / H5N1 for poultry caused by new strains in Vietnam.
- Researching to create original breeds to produce A / H5N1 influenza vaccine.
- Complete the production process of inactivated oil emulsion vaccines against industrial influenza A / H5N1 for poultry due to new strains.
The project started implementation from 2017, ending 2019.
- New prospects against avian influenza pandemic
- Restart studies of H5N1
- 4 ways to prevent influenza A
- Australia produces highly effective new anti-influenza drugs
- March 2012: Launching H5N1 vaccine for poultry
- The meaning of the names of flu strains
- H5N1 avian influenza virus
- UK: Clinically testing vaccines against all strains of influenza
- Indonesia discovered new strains of H5N1 influenza virus
- Vietnam does not export new cases of H5N1
March 2012: Launching H5N1 vaccine for poultry Experts comment on the mysterious gradual disappearance of the Delta variant in Japan Danger of the two Delta . branch variants 2020 pandemic flu attack humans? China successfully prepared the vaccine against H7N9 Scientists develop Covid-19 bait from healthy cells H7N9 can spread among family members Is flu B dangerous?